Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1645 1649 1675 1678
This examiner grants 53% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18452178 | SPATIAL SIGNALING NETWORKS FOR MULTIPLEXED DRUG RESPONSE MEASUREMENT AND MODELING | Non-Final OA | Georgia Tech Research Corporation |
| 18429055 | METHODS OF TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND MEK INHIBITORS | Non-Final OA | Genentech, Inc. |
| 17787968 | Methods for Identifying Modulators of Insect Transient Receptor Potential Channels | Final Rejection | BASF Corporation |
| 18284750 | Bispecific Molecules and Related Compositions and Methods | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18251697 | METHODS FOR DIAGNOSING OR TREATING HEALTH CONDITIONS OR OPTIMIZING THERAPEUTIC EFFICACY OF CAR-T CELLS THERAPIES | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18580710 | EARLY DETECTION OF INNATE IMMUNE DYSFUNCTION AND TREATMENT OF CONDITIONS ASSOCIATED THEREWITH | Non-Final OA | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED |
| 18546141 | LOW INTENSITY ULTRASOUND COMBINATION CANCER THERAPIES | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 18039403 | METHODS AND MATERIALS FOR TREATING T CELL CANCERS | Non-Final OA | The Johns Hopkins University |
| 17915789 | SECRETED PHOSPHORYLATED HEAT SHOCK PROTEIN-70 AS A BIOMARKER FOR TREATING AND DIAGNOSING CANCER | Final Rejection | University of Cincinnati |
| 18017841 | PEPTIDE DESIGN AND GALECTIN-3 INHIBITORS | Final Rejection | City of Hope |
| 18474419 | Use of Biomarkers in the Treatment of Fibrotic Conditions with a PDE4B-inhibitor | Non-Final OA | Boehringer Ingelheim International GmbH |
| 17769133 | Live Virus Vaccine Injury Risk | Non-Final OA | Rene Anand |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy